Delivery Order SPE2DB20D3103-SPE2DB23FP1S9
Award Date 7/31/23
Potential Completion Date 8/1/23
Potential Value $23
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $15,300 delivery order contract to Amerisourcebergen Drug Corporation for the product "4561837279 ! IPRAT-ALBUT 0.5-3(2.5) MG/3 ML UD 3ML." The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The period of performance is August 16-17, 2023. This firm fixed price order was issued against an unspecified governmentwide acquisition contract vehicle or blanket purchase agreement held by...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at ten thousand eight hundred dollars to Amerisourcebergen Drug Corporation for the product "4561655406 ! IPRAT-ALBUT 0.5-3(2.5) MG/3 ML UD 3ML." The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The period of performance is limited to one day, spanning July 31, 2023 to August 1, 2023. No additional context was provided regarding the Defense Logistics...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at $15,400 to Amerisourcebergen Drug Corporation for the product "4561955128 ! IPRAT-ALBUT 0.5-3(2.5) MG/3 ML UD 3ML." The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The period of performance is August 27-28, 2023. As the Defense Logistics Agency is responsible for worldwide logistics support of the U.S. Department of Defense, this delivery order was...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at ten thousand eight hundred dollars to Amerisourcebergen Drug Corporation for the product "4561655393 ! IPRAT-ALBUT 0.5-3(2.5) MG/3 ML UD 3ML." The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The period of performance is limited to one day, spanning July 31, 2023 to August 1, 2023. No set aside designation or subcontractors were indicated. The Defense...
- The Defense Logistics Agency awarded a $22,820 delivery order to Amerisourcebergen Drug Corporation for pharmaceutical item 4561791760. The order is for IPRAT-ALBUT 0.5-3(2.5) MG/3 ML UD 3ML to be delivered from Amerisourcebergen's facility in Conshohocken, Pennsylvania under a firm fixed price contract. The delivery order was issued on August 12, 2023 and work is scheduled for completion by August 14, 2023. As the Defense Logistics Agency is responsible for worldwide logistics support of the...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at $84,060 to Amerisourcebergen Drug Corporation for the product "4561801128 ! IPRAT-ALBUT 0.5-3(2.5) MG/3 ML UD 3ML." The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The period of performance is August 14-15, 2023. As the DLA supports the procurement of medical supplies and pharmaceuticals for the U.S. military and other government agencies, this order...
- This delivery order for $22,820 was awarded by the Defense Logistics Agency to Amerisourcebergen Drug Corporation for the supply of IPRAT-ALBUT 0.5-3(2.5) MG/3 ML UD 3ML pharmaceutical products. Place of performance will be Amerisourcebergen's facilities in Conshohocken, Pennsylvania. The firm fixed price order is for a one day period of performance from July 12 to July 13, 2023. No subcontractors or set aside designations were identified. As the Defense Logistics Agency's mission involves...
- The Defense Logistics Agency awarded a $60,720 delivery order to Amerisourcebergen Drug Corporation for pharmaceutical item 4561404311. The order is for 3 milliliter units of IPRAT-ALBUT 0.5-3(2.5) MG/3 ML UD 3ML to be delivered from Amerisourcebergen's facility in Conshohocken, Pennsylvania. The firm fixed price order is valued at sixty thousand, seven hundred twenty dollars and has a period of performance from July 4, 2023 through July 5, 2023 to support the Defense Logistics Agency's...
- The Defense Logistics Agency awarded a $60,720 delivery order to Amerisourcebergen Drug Corporation for pharmaceutical item 4561557384, described as IPRAT-ALBUT 0.5-3(2.5) MG/3 ML UD 3ML. The firm fixed price order is for product delivery to a location in Conshohocken, Pennsylvania, with performance required from July 20-21, 2023. As a major distributor of pharmaceuticals and medical supplies for the Department of Defense, this order was placed under an existing DLA pharmaceuticals contract...
- The Defense Logistics Agency awarded a $242,880 delivery order to Amerisourcebergen Drug Corporation for pharmaceutical item 4561542173. The order is for IPRAT-ALBUT 0.5-3(2.5) MG/3 ML UD 3ML to be delivered from Amerisourcebergen's facility in Conshohocken, Pennsylvania under a firm fixed price contract. As a major provider of medical supplies and pharmaceuticals to the Department of Defense, this order supports the Defense Logistics Agency's mission to provide crucial healthcare products and...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB23FP1S9Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $22,820 to Amerisourcebergen Drug Corporation for the product "4561652061 ! IPRAT-ALBUT 0.5-3(2.5) MG/3 ML UD 3ML." The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The period of performance is July 31, 2023 through August 1, 2023 under a firm fixed price contract. As the Defense Logistics Agency supports procurement for the Department of Defense, this delivery order is likely providing a pharmaceutical product in support of DOD medical readiness and treatment programs. No major subcontractors or set aside designations were indicated.
Generated 12/20/23, 11:07 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $23 | 7/31/23 |